PharmaShots | Incisive News in 3 Shots

Subscribe Now

Relapsing Multiple Sclerosis

Novartis Reports Results of Ofatumumab (OMB157) in P-III ASCLEPIOS Trials for Relapsing Multiple Sclerosis

Novartis Reports Results of Ofatumumab (OMB157) in P-III ASCLEPIOS Trials for Relapsing Multiple Sclerosis

August 6, 2020

Janssen Reports Results of Ponesimod in P-III OPTIMUM Study for Relapsing Multiple Sclerosis in Adults

Janssen Reports Results of Ponesimod in P-III OPTIMUM Study for Relapsing Multiple Sclerosis in Adults

September 12, 2019

Celgene Files NDA for Ozanimod to the US FDA for Relapsing Forms of Multiple Sclerosis (RMS)

Celgene Files NDA for Ozanimod to the US FDA for Relapsing Forms of Multiple Sclerosis (RMS)

March 26, 2019

FDA to Refuse Celgene for Filling Ozanimod's NDA for the Treatment of Relapsing Multiple Sclerosis

FDA to Refuse Celgene for Filling Ozanimod's NDA for the Treatment of Relapsing Multiple Sclerosis

February 27, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us